Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment Resistant Psychosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchUnknownNCT06270108
What this trial is testing

The Role of Glutamatergic Function in the Pathophysiology of Treatment-resistant Schizophrenia

Who this might be right for
Treatment-resistant SchizophreniaTreatment-responsive SchizophreniaHealthy Controls
King's College London 288
Not applicableStudy completedNCT03585127
What this trial is testing

Avatar Therapy in Comparison to Cognitive Behavioral Therapy for Treatment-resistant Schizophrenia

Who this might be right for
Auditory Hallucination, VerbalTreatment-resistant Schizophrenia
Ciusss de L'Est de l'Île de Montréal 74
Large-scale testing (Phase 3)Not Yet RecruitingNCT07326124
What this trial is testing

Stratification and Treatment in Early Psychosis Study -ASSIST

Who this might be right for
Treatment Resistant PsychosisPsychosis
University of Oxford 250
Testing effectiveness (Phase 2)Study completedNCT00154258
What this trial is testing

A Long Term Study of Clozapine in Patients With Treatment-resistant Schizophrenia

Who this might be right for
Schizophrenia
Novartis 19
Not applicableLooking for participantsNCT07091344
What this trial is testing

Cognitive and Metacognitive Evaluation in VR-Based Avatar Therapy for Psychosis

Who this might be right for
Schizophrenia DisordersTreatment Resistant Hallucinations
Fundació Sant Joan de Déu 30
Not applicableStudy completedNCT02105064
What this trial is testing

Repetitive Transcranial Magnetic Stimulation (rTMS) as an add-on Treatment for Resistant Obsessive-compulsive Symptoms in Patients With Schizophrenia

Who this might be right for
SchizophreniaObsessive-Compulsive Symptoms
Hospital de Clinicas de Porto Alegre 12
Not applicableStudy completedNCT00448630
What this trial is testing

An Observational Study On Metabolic Syndrome Parameters In Schizophrenia Patients Treated With Atypical Antipsychotics

Who this might be right for
SchizophreniaMetabolic Syndrome X
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 328
Not applicableLooking for participantsNCT04798131
What this trial is testing

FMRI-based Neurofeedback to Relieve Drug-resistant Auditory Hallucinations

Who this might be right for
SchizophreniaHallucinations, AuditoryHallucinations, Visual
University Hospital, Lille 84
Post-approval studies (Phase 4)Study completedNCT00231335
What this trial is testing

Efficacy and Safety Study of Escitalopram Augmentation in Treatment Resistant Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
Emory University 30
Not applicableLooking for participantsNCT05543083
What this trial is testing

Cognitive-Behavioral Therapy and Exercise Training in Adolescents At-Risk for Type 2 Diabetes

Who this might be right for
Insulin ResistanceDepressionDepressive Disorder+5 more
Colorado State University 300
Post-approval studies (Phase 4)Study completedNCT03652974
What this trial is testing

Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy

Who this might be right for
Schizophrenia
Shanghai Mental Health Center 145
Post-approval studies (Phase 4)Study completedNCT00231894
What this trial is testing

Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With Schizophrenia

Who this might be right for
DiabetesSchizophreniaInsulin Resistance+1 more
Nathan Kline Institute for Psychiatric Research 56
Post-approval studies (Phase 4)Study completedNCT00287820
What this trial is testing

Comparative Effects of Chronic Treatment With Olanzapine and Risperidone on Glucose and Lipid Metabolism

Who this might be right for
SchizophreniaDiabetesMetabolic Syndrome+1 more
Nathan Kline Institute for Psychiatric Research 46
Large-scale testing (Phase 3)Study completedNCT02717195
What this trial is testing

Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia

Who this might be right for
Schizophrenia
H. Lundbeck A/S 1,098
Not applicableUnknownNCT06128408
What this trial is testing

The Characteristics of Treatment Resistant Schizophrenia From the Illness Onset

Who this might be right for
Treatment-resistant Schizophrenia
Peking University 300
Not applicableNot Yet RecruitingNCT06748950
What this trial is testing

Ketogenic Metabolic Therapy in Schizophrenia, Bipolar Disorder, Major Depressive Disorder: Deep Omic Profiling

Who this might be right for
SchizophreniaSchizophrenia and Related DisordersBipolar Disorder+7 more
Stanford University 120
Post-approval studies (Phase 4)Active Not RecruitingNCT07047651
What this trial is testing

Τhe Combination of Pharmacotherapy With RECOVERYTRSGR and RECOVERYTRSBDGR.

Who this might be right for
Treatment Resistant SchizophreniaTreatment Resistant Bipolar Disorder
Dr. Stavroula Rakitzi 84
Not applicableStudy completedNCT04025073
What this trial is testing

The Impact of Dietary Habits and Nutrition Intervention on Metabolic Syndrome in Individuals With Schizophrenia

Who this might be right for
Metabolic Syndrome
Tamara Sorić 79
Not applicableStudy completedNCT07183982
What this trial is testing

Multidisciplinary Rehabilitation Program for Treatment-Resistant Psychotic Forensic Patients: A Comparative Study

Who this might be right for
Schizophenia DisorderForensic Psychiatric Patients
Oman Ministry of Health 20
Large-scale testing (Phase 3)Looking for participantsNCT03094429
What this trial is testing

An Adaptive Phase II/III, Two-Part, Double-Blind, Randomized, Placebo-controlled, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen®, as an Add-on Therapy With Clozapine, for Residual Symptoms of Refractory Schizophrenia in Adults

Who this might be right for
Refractory Schizophrenia
SyneuRx International (Taiwan) Corp 287
Next Page